Status:
TERMINATED
Validation of the HYPONUT Product
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Peanut Allergy
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
The HYPONUT product was previously validated in a laboratory setting ("Procédé de préparation d'aliment hypoallergénique", n° FR1250977) on 2012. A international patent was then obtained on 2013. Thro...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients aged more than 6
- Patients suffering from peanut allergy and followed in the Allergy Unit of the University Hospital of Montpellier (France)
- Exclusion criteria:
- Pregnancy, or patients breast-feeding
- Patients treated with drugs possibly altering the results of the tests (e.g. anti-histamines)
- Patients presenting with dermographism
- Patients not fluent in French
Exclusion
Key Trial Info
Start Date :
September 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 4 2020
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03849079
Start Date
September 24 2019
End Date
February 4 2020
Last Update
November 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Montpellier, Hérault, France, 34090